Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: A balance between stimulation by spores and differential disruption by toxins

PLoS Pathogens

Volumn 8, Issue 1, 2012, Pages

  Klezovich Bénard, Maria ^a,b   Corre, Jean Philippe ^a,b   Jusforgues Saklani, Hélène ^a   Fiole, Daniel ^c,d   Burjek, Nick ^a,b   Tournier, Jean Nicolas ^c,e   Goossens, Pierre L ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^d LIPHY   (France)

^e Ecole du Val de Grace   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; BACTERIAL TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; EDEMA; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SIGNAL TRANSDUCTION; T CELL DEPLETION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELLULAR IMMUNITY; DRUG EFFECT; HOMEOSTASIS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

ANIMALS; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELLS, CULTURED; FEMALE; HOMEOSTASIS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR CROSS-TALK; SPORES, BACTERIAL;

EID: 84857465055     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002481     Document Type: Article

References (88)

1. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nat Immunol 9: 503-510.
2. Schoenborn JR, Wilson CB, (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96: 41-101.
3. Chiesa S, Mingueneau M, Fuseri N, Malissen B, Raulet DH, et al. (2006) Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107: 2364-2372.
4. Lapaque N, Walzer T, Meresse S, Vivier E, Trowsdale J, (2009) Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 182: 4339-4348.
5. Newman KC, Riley EM, (2007) Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 7: 279-291.
6. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A, (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
7. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ, (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14: 361-368.
8. Sporri R, Joller N, Hilbi H, Oxenius A, (2008) A novel role for neutrophils as critical activators of NK cells. J Immunol 181: 7121-7130.
9. Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, et al. (2011) The role of natural killer cells in sepsis. J Biomed Biotechnol 2011: 986491.
10. Glomski IJ, Fritz JH, Keppler SJ, Balloy V, Chignard M, et al. (2007) Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol 9: 502-513.
11. Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M, (1999) Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 31: 9-17.
12. Guidi-Rontani C, (2002) The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol 10: 405-409.
13. Kang TJ, Fenton MJ, Weiner MA, Hibbs S, Basu S, et al. (2005) Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun 73: 7495-7501.
14. Tournier JN, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT, (2009) Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol Aspects Med 30: 456-466.
15. Cromartie WJ, Bloom WL, Watson DW, (1947) Studies on infection with Bacillus anthracis; a histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J Infect Dis 80: 1-13.
16. Leppla SH, (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A 79: 3162-3166.
17. Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C, (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352 Pt 3: 739-745.
18. Moayeri M, Leppla SH, (2004) The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 7: 19-24.
19. Mourez M, (2004) Anthrax toxins. Rev Physiol Biochem Pharmacol 152: 135-164.
20. Szarowicz SE, During RL, Li W, Quinn CP, Tang WJ, et al. (2009) Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Infect Immun 77: 2455-2464.
21. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, et al. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
22. Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, et al. (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174: 4934-4941.
23. Joshi SK, Lang GA, Larabee JL, Devera TS, Aye LM, et al. (2009) Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy. PLoS Pathog 5: e1000588.
24. Fang H, Xu L, Chen TY, Cyr JM, Frucht DM, (2006) Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J Immunol 176: 6155-6161.
25. Paccani SR, Tonello F, Ghittoni R, Natale M, Muraro L, et al. (2005) Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med 201: 325-331.
26. Fang H, Cordoba-Rodriguez R, Lankford CS, Frucht DM, (2005) Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cells. J Immunol 174: 4966-4971.
27. Gold JA, Hoshino Y, Hoshino S, Jones MB, Nolan A, et al. (2004) Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect Immun 72: 1291-1297.
28. Glomski IJ, Corre JP, Mock M, Goossens PL, (2007) Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol 178: 2646-2650.
29. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR, (1997) Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467.
30. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, et al. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
31. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH, (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119-126.
32. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, et al. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29.
33. Chaix J, Tessmer MS, Hoebe K, Fuseri N, Ryffel B, et al. (2008) Cutting edge: Priming of NK cells by IL-18. J Immunol 181: 1627-1631.
34. Ljunggren HG, Karre K, (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11: 237-244.
35. Trinchieri G, (1989) Biology of natural killer cells. Adv Immunol 47: 187-376.
36. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
37. Hamerman JA, Ogasawara K, Lanier LL, (2004) Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 172: 2001-2005.
38. Backstrom E, Kristensson K, Ljunggren HG, (2004) Activation of natural killer cells: underlying molecular mechanisms revealed. Scand J Immunol 60: 14-22.
39. Semino C, Angelini G, Poggi A, Rubartelli A, (2005) NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106: 609-616.
40. Walzer T, Dalod M, Vivier E, Zitvogel L, (2005) Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 5 (Suppl 1): S49-59.
41. Schluns KS, Stoklasek T, Lefrancois L, (2005) The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both? Int J Biochem Cell Biol 37: 1567-1571.
42. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, et al. (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275.
43. Carson W, Caligiuri MA, (1998) Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res 31: 1-9.
44. Haeberlein S, Sebald H, Bogdan C, Schleicher U, (2010) IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. Eur J Immunol 40: 1708-1717.
45. Sareneva T, Julkunen I, Matikainen S, (2000) IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 165: 1933-1938.
46. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, et al. (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
47. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, et al. (1998) Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188: 1485-1492.
48. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, et al. (1998) IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161: 3400-3407.
49. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, et al. (1997) Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275: 206-209.
50. Nickel W, (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270: 2109-2119.
51. Stanley AC, Lacy P, (2010) Pathways for cytokine secretion. Physiology (Bethesda) 25: 218-229.
52. Grohmann U, Belladonna ML, Vacca C, Bianchi R, Fallarino F, et al. (2001) Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J Immunol 167: 221-227.
53. Bastos KR, de Deus Vieira de Moraes L, Zago CA, Marinho CR, Russo M, et al. (2005) Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice. Immunology 114: 499-506.
54. Bastos KR, Marinho CR, Barboza R, Russo M, Alvarez JM, et al. (2004) What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells? Microbes Infect 6: 630-636.
55. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
56. Arend WP, Palmer G, Gabay C, (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38.
57. Maier LM, Howlett SK, Rainbow KM, Clark J, Howson JM, et al. (2008) NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice. J Immunol 181: 7073-7080.
58. Fukao T, (2004) Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect Dis 4: 166-170.
59. Moayeri M, Leppla SH, (2009) Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 30: 439-455.
60. Hoover DL, Friedlander AM, Rogers LC, Yoon IK, Warren RL, et al. (1994) Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun 62: 4432-4439.
61. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C, (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett 462: 199-204.
62. Mariathasan S, Monack DM, (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40.
63. Martinon F, Gaide O, Petrilli V, Mayor A, Tschopp J, (2007) NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29: 213-229.
64. Kang TJ, Basu S, Zhang L, Thomas KE, Vogel SN, et al. (2008) Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways. Eur J Immunol 38: 1574-1584.
65. Wickliffe KE, Leppla SH, Moayeri M, (2008) Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell Microbiol 10: 332-343.
66. Tupin E, Kinjo Y, Kronenberg M, (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5: 405-417.
67. Tupin E, Kronenberg M, (2006) Activation of natural killer T cells by glycolipids. Methods Enzymol 417: 185-201.
68. Ahuja N, Kumar P, Bhatnagar R, (2004) The adenylate cyclase toxins. Crit Rev Microbiol 30: 187-196.
69. Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, et al. (2010) The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 11: 121-128.
70. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, et al. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169: 2818-2822.
71. de Saint Basile G, Menasche G, Fischer A, (2010) Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 10: 568-579.
72. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, et al. (1993) Evidence of perforin-mediated cardiac myocyte injury in acute murine myocarditis caused by Coxsackie virus B3. J Pathol 170: 53-58.
73. van Sorge NM, Ebrahimi CM, McGillivray SM, Quach D, Sabet M, et al. (2008) Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS One 3: e2964.
74. Cote CK, Rea KM, Norris SL, van Rooijen N, Welkos SL, (2004) The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37: 169-175.
75. Dumetz F JG, Khun H, Glomski IJ, Corre J-P, Rougeaux C, et al. (2011) Noninvasive imaging technologies reveal Edema toxin as a key virulence factor in anthrax. Am J Pathol: 178: 2523-2535.
76. Trapani JA, Smyth MJ, (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2: 735-747.
77. Bancroft GJ, (1993) The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5: 503-510.
78. Brossier F, Mock M, (2001) Toxins of Bacillus anthracis. Toxicon 39: 1747-1755.
79. Berthier M, Fauchere JL, Perrin J, Grignon B, Oriot D, (1996) Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan. Lancet 347: 828.
80. Brossier F, Levy M, Mock M, (2002) Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun 70: 661-664.
81. Sylvestre P, Couture-Tosi E, Mock M, (2005) Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the bacillus anthracis exosporium. J Bacteriol 187: 5122-5128.
82. Pezard C, Duflot E, Mock M, (1993) Construction of Bacillus anthracis mutant strains producing a single toxin component. J Gen Microbiol 139: 2459-2463.
83. Park SH, Guy-Grand D, Lemonnier FA, Wang CR, Bendelac A, et al. (1999) Selection and expansion of CD8alpha/alpha(1) T cell receptor alpha/beta(1) intestinal intraepithelial lymphocytes in the absence of both classical major histocompatibility complex class I and nonclassical CD1 molecules. J Exp Med 190: 885-890.
84. Jung T, Schauer U, Heusser C, Neumann C, Rieger C, (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159: 197-207.
85. Marcusson-Stahl M, Cederbrant K, (2003) A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studies. Toxicology 193: 269-279.
86. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, et al. (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6: 928-937.
87. Wang X, Zhang F, Chen F, Liu D, Zheng Y, et al. (2011) MEKK3 regulates IFN-gamma production in T cells through the Rac1/2-dependent MAPK cascades. J Immunol 186: 5791-5800.
88. Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL, (2007) Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3: e76.